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The cell walls of Gram-positive bacteria are complex structures which con- 
tain somatic antigens such as teichoic acids  (1-3), polysaccharides (4--6),  and 
teichuronic acids (7), mad in many instances complete extraction of these anti- 
gens yields an insoluble residue composed almost entirely of mucopeptide (8). 
The chemical composition of mucopepfide is primarily limited to N-acetylglu- 
cosamine, N-acetylmuramic acid, and a few amino acids including alanine, gin- 
tamic acid, glycine, lysine, and diaminopimelic acid, although some variation 
in amino acid content is noted among the different species of bacteria (9, 10). 
The macromolecular structure of mucopeptide consists of a polymer of repeat- 
ing units of N-acetylglucosamine  and  peptide-linked  N-acetylmuramic  acid. 
The peptides of the repeating units are further cross-linked by peptide bridges 
which connect the separate backbone hexosamine polymers to form the rigid 
structure of bacterial cell walls (11, 12). 
Although the immunochemical features of the cell wall antigens have been 
studied in detail, little attention has been directed to the immune response to 
mucopeptides or to their immunochemical features. In view of the widespread 
occurrence of mucopeptide among all species of bacteria, it is conceivable that 
mucopeptide antibodies may be an important element in various aspects of the 
host response to infections, such as immunity and hypersensitivity. Although 
previous reports have demonstrated antibodies in rabbits hyperimmunized with 
bacterial vaccines (13,  14),  the immunochemical basis for the antigenic speci- 
ficity has not been elucidated. This report describes a  precipitin reaction be- 
tween streptococcal mucopeptide and mucopeptide antibodies and defines in 
immunochemical terms an antigenic basis for the specificity of this  reaction. 
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Materials and Methods 
Strains  of Strepto¢occi.--Streptococcal strains were  obtained from Dr.  R.  C.  Lancefield, 
the Rockefeller University. 
Preparation of Cell Walls.--Cell  walls were prepared from Groups A ($43/100), A-variant, 
(T27A), B  (090R), C  (H46A), D  (D76),  F  (H127), and G  (B549) streptococci according to 
the method of Bleiweis et 81. (15). 
Preparation of Mucopeptide.--Mucopeptides  were extracted and prepared from cell walls 
by the hot formamide method of Fuller (16)  as described by Kranse and McCarty (8). 
Cell Wall Lyric Enzyraes.--Egg-white lyso~yme was obtained from Mann Research Labora- 
tories, New York. The Streptomyces albus enzymes were prepared as described by McCarty 
(17). 
Analyl~ical Methods.--Quantitative  analysis of hexosamines and amino acids were deter- 
mined by the method of Moore et al.  (18,  19)  and employed  the Beckman, Spinco model 
120B amino acid analyzer.  10 nag of a  dried sample was placed into an acid-cleaned pyrex 
tube (8 X  125 ram) and dissolved in 5.0 ml of 4 N HC1. The tube was sealed and hydrolyzed 
at 105°C for 14 hr in a constant temperature chromatographic oven. The hydrolyzed content 
was then transferred to a 50 ml beaker and evaporated to dryness at room temperature in a 
vacuum dessicator containing NaOH pellets. The dried sample was rehydrated with distilled 
water and again evaporated to dryness.  After this procedure was  repeated  three times to 
remove the remainder of the HCI,  the dried sample was dissolved in 0.2 M sodium citrate, 
pH 2.2.  A 1 ml (1 mg/ml) samplewas employed for analysis. Correction for the minimal deg- 
radation of hexosamines which was encountered during the HCI hydrolysis of mucopeptide 
was achieved by determining the rates of decomposition of both amino sugar standards under 
identical hydrolysis conditions. A  correction value was employed to calculate the muramic 
acid and glucosamine content of the mucopeptide. 
Ion-gx~hangg Chromatography of S.  albus Enzymes  Lysate.--Diethylaminoethylcellulose 
(DEAE, Gallard-Schlesinger Chemical Manufacturing Corp., New York, 0.68 meq/g) columns 
were prepared by the method previously described by Young for the fractionation of bac- 
terial cell wall components (20). DEAE-cellulose was regenerated by washing with a solution 
containing 0.125 u  NaOH and 0.125 M NaC1.  A slurry was employed  to construct a  300 X 
25 mm column which was packed with 5 lb./sq in. nitrogen pressure at room  temperature. 
The column was washed with six volumes of 0.4 HC1 and equilibrated with 0.02 ~  (NH4)~COa, 
pH 8.6, and stored at 4°C. 
Between 50 and 100 mg of dlalyzable material obtained from an S. albus enzymes digest 
of cell walls was dissolved in 10 mi of 0.2 ~  (NH4)2COs  and applied to the  DEAE-ceUulose 
columu which was then eluted at 4°C with 0.02 ~  (NH4)~CO3 buffer at a flow rate of 30 ml/hr. 
The einate was collected in 3 ml fractions, and the eluted material was detected in the frac- 
tions by measuring the optical density at 220 nag in a spectrophotometer. After fractions were 
obtained which exhibited an absorbency of less than 0.10,  the next elution step with a higher 
concentration of buffer was initiated. The successive elution steps were 0.02, 0.05,  0.075, 0.10, 
0.15, 0.20, 0.30, and 0.50 x~ (NH4)2CO3 buffer. 
Gel Filtration of Cell Wall Products.--The  cell wall materials recovered in the fractions 
from the DEAE column were subjected to gel titration (21). A distilled water slurry of Sepha- 
dex G-25 or G-50  (Pharmacla Fine Chemicals, Uppsala,  Sweden) was poured into a  700  X 
10 mm column and washed with approximately 12 volumes of distilled water. A  1 ml sample 
was added to the column and eluted with distilled water. The optical density of 3 ml fractions 
was measured in the spectrophotometer at 220 m#. Samples were also eluted off the Sephadex 
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Serological Methods.---Quantitative precipitin  analyses  were  performed  according  to  a 
modi.fication of a method  of McCarty (22) as described by Abdulla and Schwab (14). The 
antigen-antibody  precipitate  after washing with cold saline was dissociated with 0.1 ~ NaOH 
and assayed photometrically at 280 m/~. Correction for the slight opalescence of the dissolved 
precipitate  which is derived from the mucopepfide was achieved by subtracting  the 320 m/~ 
value from the 280 m# value. With most sera at antigen-antibody  equivalence, the optical 
density at 320 ha# was approximately 20% of the value at 280 m#. 
The capillary precipitin test for the detection of mucopepfide antibodies was performed in 
a manner similar to that employed by Swift, Wilson, and Lancefield for the detection of group- 
specific antibodies (23). 
Antimucopeptide  sera were obtained  from rabbits  which had been imrn~  intraven- 
ously with particulate  cell wall mucopeptide. The mucopeptide, free of nearly all group carbo- 
hydrate, was obtained by acid extraction  of cell walls at pH 0.5 at 100°C for 30 rain. The 
immunization  schedule was similar to that employed by McCarty and Laneefield (24) to 
raise streptococcal group-specific antibodies. 
Certain  streptococcal  grouping  antisera  which  contained  mucopeptide  antibodies  were 
generously supplied by Dr. R. C. Lancefidd,  the Rockefeller University. 
Mucopeptide  which had been solub'flized by ultrasonic  treatment was employed in the 
precipitin  tests.  The mucopeptide, suspended in distilled water,  was cooled by  an ice-bath 
during treatment for 15 min in a 20 kc sonic oscillator. 
Lysozyme digestion was also employed to solub'flJze the mucopeptide  antigen.  Mucopep- 
tide, suspended in 0.07 M  phosphate  buffer (pit 7.4) containing 125 #g/ml of lysozyme, was 
incubated  at 370C for 24 hr. After incubation, the lysate was deproteinized  with chloroform 
according to a method described by Heymann et ai. (25). The final product was employed in 
mucopeptide-precipitin reactions. 
RESULTS 
Chem~d  and Antigenic  Properties of Mucopeptide.--The  mucopeptides  ex- 
tracted  by  the  hot  formamide  method  from  cell  walls  of various  groups  of 
streptococci exhibited a  similax chemical composition. Depicted in Table I  axe 
the results  of chemical analyses of Groups A-variant,  B,  C-vaxiant,  F,  and G 
streptococcal mucopeptide  residues.  It is  to be noted  that  the mucopeptides 
isolated from the several different groups possessed identical chemical constit- 
uents,  and the mole ratios  are consistent  with  the previous findings of other 
investigators (26-29).  In each case there are approximately 4  moles of alanine 
for each mole of glutamic acid and lysine. In general,  the mole concentration 
of glucosamine is somewhat greater than that of muramic acid. 
An antibody response to mucopeptide was achieved by the immunization of 
rabbits with mucopeptides of Groups A  and C  streptococci. Mucopeptide anti- 
bodies were detected  in the sera collected at 7-day intervals  by  the  capillary 
precipitin  method.  During the course of immunization  an  increase in  precip- 
itin  activity of the rabbits' sera corresponded to an increase in proteins in the 
,y-giobulin region of the electrophoretic pattern. Immunoelectrophoresis studies 
confirmed the 3,G-globulin nature of the antimucopeptide precipitins.  Immune 
serum was placed into the central well of an immunodiffusion slide and, after 158  STREPTOCOCCAL  MUCOPEPTIDE 
electrophoresis, solubilized mucopeptide was placed into one trough and spe- 
cific rabbit  anti-~,G into  the  other. A  distinct precipitin line developed be- 
tween the mucopeptide and antiserum in an area comparable to that which 
developed between anti-rabbit "},G and rabbit v-globulin. 
Depicted in Fig.  1 are the results of quantitative precipitin tests obtained 
between  Groups A,  B,  C,  and F  mucopeptides and  Group A-variant serum 
rich in mucopeptide antibodies. It is immediately apparent that mucopeptides 
of the various groups react with antibodies raised against Group A-variant mu- 
copeptide. This finding suggests that an antigenic determinant is shared by the 
different mucopeptides and is consistent with the fact that these mucopeptides 
have a similar chemical composition. 
TABLE I 
Chemical Composition of Formamide-Extracted Mucopeptide of Groups A-variant, 
B, C-variant, F, and G Streptococci 
Components 
Glucosamine 
Muramic acid 
Alanine 
Glutamic acid 
Lysine 
Glyc'me 
Ammonia 
A-varlant 
0. 537 
0.383 
2.476 
0.640 
0.602 
0.028 
1.034 
B 
0.704 
0.664 
2. 530 
0. 762 
0.666 
0.024 
1.420 
Group 
C-varlant 
Izmote/mg 
0.558 
0.531 
2.564 
0.784 
0.605 
0.034 
1.149 
0.663 
0.573 
2.541 
0.659 
0.659 
0.022 
1.488 
G 
0.557 
0.390 
2.480 
0.624 
0.616 
, 
1.254 
* Trace amounts. 
Mucopeptides are made up of three principal moieties: the hexosamine poly- 
mer consisting of repeating units of N-acetylglucosamine and N-acetylmuramic 
acid; pepfides linked to the polymer through the muramic acid residues; and 
amino acid or peptide bridges which cross-link the pepfides associated with ad- 
jacent hexosamine polymers. It is conceivable that any one of these components, 
or a combination of them, may function as an antigenic determinant. Methods 
were devised to isolate an inhibitory haptenic fraction from purified mucopep- 
tide which was enzymatically digested by the S. albus enzymes. These enzymes 
have been shown to solubilize the mucopeptide with the release of the hexosa- 
mine fractions and peptides (17). 
Degradation Products Rdeased from Cell Walls by Enzymatic Treatment.--Pre- 
vious studies have shown that, in the case of Micrococcus  lysodeikticu~,  lyso- 
zyme solubilizes mucopepfide by hydrolyzing the  1,4 glycosidic linkage of the 
hexosamine polymer with  the  release  of glucosamine-muramic  acid-peptide WALTER  W. ~AWA  AND  RICHARD  M. KRAUSE  159 
units of varying sizes (30). In the work reported here, mucopeptide solubilized 
with lysozyme retained serologic reactivity with mucopeptide antiserum. 
In contrast to these results achieved with lysozyme, S. a/bus enzymes com- 
pletely destroyed the serological reactivity of the mucopeptide.  Furthermore, 
gel filtration studies indicate that the bulk of the mucopeptide following S. a/- 
bus enzymes digestion consists of heterogeneous fragments considerably  smaller 
than the mucopeptide solubilized by lysozyme treatment or sonic treatment. 
The results of gel filtration on Sephadex G-50 of sonically disrupted mucopep- 
tide and lysozyme and S. albus enzymes digests of mucopeptide are illustrated 
in Fig. 2. Mucopeptide solubilized by sonication  was eluted off the Sephadex 
G-50 column at void volume.  Although the bulk of the mucopeptide treated 
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FIO.  1.  Quantitative  precipitin  reaction  between  sonicaUy disrupted  mucopeptides  of 
Groups A, B, C, and F streptococci, and mucopeptide antiserum. 
with lysozyme  was eluted at void volume, appreciable material was retarded on 
the column. Thus a portion of the mucopeptide has been digested to heteroge- 
neous units which are smaller than the sonically disrupted mucopeptide. In con- 
trast to these results,  all mucopeptide hydrolyzed with S. a/bus enzymes was 
eluted after void volume. The broad peak of the retarded elution pattern indi- 
cates a marked degree of fragmentation of the mucopeptide into small hetero- 
geneous components which are retarded to a greater degree than those obtained 
with lysozyme. 
The presence of a haptenic inhibitor of the mucopeptide precipitin reaction 
in the S. a/bus enzymes digest of mucopeptide was detected by quantitative pre- 
cipitin-inhibition  tests. The mucopeptide  fractions from Groups B and G, col- 
lected after void volume off a Sephadex G-S0 column as depicted in Fig. 2, were 
employed as inhibitors of the precipitin reaction between Group B mucopeptide 160  STREPTOCOCCAL  MIYCOPEPTIDE 
and mucopeptide  antiserum. As depicted in Fig. 3, Groups B and D mucopep- 
tide fractions in concentrations  as low as 6 mg/ml markedly inhibited the reac- 
tion. Although a preparation of S. a/bus enzymes contains a lysozymelike en- 
zyme, it is unlikely that this enzyme destroys the reactivity of the mucopeptide 
because  egg-white lysozyme is ineffective in this respect.  On the other hand, 
another  of theS. a/bus enzymes, N-acetylmuramyl  L-alanine  arrAdase,  splits off the 
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F~O. 2.  Gel filtrsfion on s  Seph~iex G-50 column  of sonically  disrupted,  lysozyme-di- 
gested, and S. ~  enzymes--digested Group B  mucopepfide preparations. Col~lmn  dimen- 
sions: 700 X  10 ram. WALTER  W.  KARAKAWA AND  RICHAPJ)  M.  KRAUSE  161 
peptide moiety linked to the muramic acid (31). It is thus conceivable that this 
amidase may have released the peptide from the hexosamine polymer and elim- 
inated the precipitin reactivity of the mucopeptide. This possibility was inves- 
tigated in the following experiment. 
Isolation of Inhibitory Hapten from an S. albus Enzymes Digest of Mucopep- 
tide.--900 mg of Group D  cell walls, after treatment with 10 % trichloroacetic 
acid at 4°C to remove the bulk of the group and type antigens, were suspended 
in 25 ml of 0.005 ~  ammonium acetate (pH 8.0). 25 ml of concentrated S. albus 
enzymes preparation was added to the cell wall suspension and the mixture was 
incubated at 45°C for 24 hr according to the method of McCarty (17). The di- 
gest was dialyzed in cellophane tubing against frequent changes of distilled 
.,.,i 
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Fro. 3. Quantitative precipitin inhibition  of the Group B mucopeptide  reaction  by dialyz- 
able S. a/bus enzymes  digests of Groups B and D mucopeptide. 
water. The dialysates were pooled, concentrated, and lyophilized. In the major- 
ity of the experiments the lyophilized dialyzable product was resuspended in a 
small volume of 0.02 M (NI-I,)2CO3 and added to the DEAE-cellulose col-ran. 
Twelve fractions were obtained using (NI-L)~CO3  buffer with increasing molar- 
ities from 0.02  to 0.5 ~. However, upon analyzing the fractions for inhibitory 
activity by the capillary precipitin method, it was found that only fractions II 
and  III,  which  were  eluted  off  the  DEAE-cellulose  column  with  0.02  M 
(NI-I4)2CO3, possessed mucopeptide inhibitory properties. Depicted in Fig. 4 is 
the elution pattern from the DEAE-cellulose column with 0.02  ~  (NI-I4)2COs. 
The three major fractions eluted at this buffer concentration were designated 
fractions I, II, and III. 
In the case of several selected mucopeptide antisera, fraction I, which repre- 
sents the fall-through peak, possessed no inhibitory activity, whereas fraction 162  STREPTOCOCCAL  M'UCOPEPTIDE 
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Fro. 4.  DEAE-cellulose  column chromatography of an S. a/bus enzymes digest of Group 
D  cell walls.  Column  dimensions:  300  X  25  ram.  Buffer:  0.02 M ammonium  carbonate 
(NI~)~CO3, pH 8.6 at 4°C. 
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FIG. 5.  Gel filtration on a  Sephadex G-25 column of the fraction HI eluted from  DEAE- 
cellulose column depicted in Fig. 4. This fraction was an inhibitor of the mucopeptide preci- 
pitin reaction. Column dimensions: 700 X  10 ram. 
III was a very potent inhibitor. Fraction II was inhibitory, but less active than 
fraction III.  Fraction III was further purified by gel filtration. Illustrated in 
Fig. 5 is the elution pattern of fraction III on a  Sephadex G-25 column, which 
had a  void volume of 19.0 ml as determined by the elution of lysozyme (tool 
wt 14,700). This elufion pattern clearly suggests that the molecular weight was WALTER  W.  KARAKAWA AND  RICHARD  M.  KRAUSE  163 
less than 5000. Depicted in Fig. 6 is the pattern obtained when the pooled prod- 
uct from the coll]mn of Fig. S is subjected to repeated DEAE chromatography. 
Fraction HI was noted  to  be  the major peak which was  eluted by 0.02  x~ 
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FIG. 6.  DEAE-cellulose CO]11mn chromatography of the inhibitory material collected from 
the pooled peak fractions depicted in Fig. 5. Column dimensions: 300  X  25 ram. 
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FiG. 7.  Gel filtration on a  Sephadex G-2S column of the inhibitory material  collected  in 
the peak fractions eluted from the DEAE column depicted in Fig. 6 with 0.02 x, (NH02CO3. 
Colnmn dimensions: 700 X  10 ram. The peak fractions off this Sephadex column were pooled 
and  designated  purified fraction  HI.  This material was  employed in  subsequent  chemical 
and immunological analyses. 
(NI-I,),CO3 buffer and only minimal material was eluted at volumes similar to 
that for fractions I  and II. The buffer was removed from the pooled material 
containing fraction II, and the product, again purified by G-25 gel filtration, is 
illustrated in Fig. 7. The peak fractions illustrated in this figure were pooled and 164  STREPTOCOCCAL M-~COPEPTIDE 
employed in subsequent chemical and immunological analyses. In a similar man- 
ner, DEAE fractions I  and II were also purified by G-25 gel filtration and re- 
cycled through DEAE-cellulose and  again on a  Sephadex  G-25  column. The 
purified fractions, I, II, and III, were tested for serological inhibitory activity. 
Fraction I had minimal inhibitory activity, fraction II was inhibitory, but frac- 
tion III was a markedly active inhibitor. 
Depicted in Table II are the results of the chemical analyses of Group D  cell 
TABLE II 
Chemical Composition of Dialyzable Fractions of Group D Cell Walls Treated 
with S. albus Enzymes 
Components 
I~mole/mg 
Glucosamine 
Muramic acid 
Alanine 
Glutamic acid 
Lysine 
Aspartic acid 
Threonine 
Serine 
Glycine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Galactosamine 
Ammonia 
Cell walls 
0.533 
0.239 
1.360 
0.330 
0.328 
0.029 
0.015 
0.015 
0.024 
0.019 
0.011 
0.020 
0.008 
0.009 
0.278 
0.485 
Elutions of DEAE-ceUulose  column 
Fraction  Fraction 
I  II 
1.080  0.118 
0.990  0.111 
0.174  4.934 
0.052  1.308 
0.052  1.389 
0.006  0.008 
--  0.009 
0.011  0.007 
0.010  0.022 
--  0.011 
--  0.005 
1.381  2.009 
50.3"  92.8 
Fraction 
III 
0.030 
0.026 
5.267 
1.448 
1.372 
0.022 
1.613 
Total recovery, %  44.9"  92.6 
* These recovery  values do not include rhamuose, glucose, and galactose. 
walls and purified fractions I, II, and III. As illustrated in this table, fraction 
III was composed of alanine, glutamic acid, and lysine, with only trace amounts 
of hexosamines. Thus the major peptide moiety of the mucopeptide has been 
isolated in this fraction. The original amino acid chromatographic analysis of 
fraction III is illustrated in Fig. 8. It should be noted that only the major amino 
acids of mucopeptide were detected in this chromatogram. These amino acids 
plus ammonia represent approximately 92 % of the total weight of the sample 
applied to the column. Fraction I  was composed primarily of glucosamine and 
muramic acid in a mole ratio of 1:1 and had a minimal concentration of amino WALTER  W.  KARAKAWA  AND  RICHARD  M.  K.RAUSE 
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acid residues. The original chromatographic analysis of this fraction is depicted 
in Fig. 9. This fraction had minimal inhibitory activity. The bulk of fraction II 
consists of amino acids, but there is an appreciable content of hexosamines.  This 
fraction inhibits the precipitin reaction, but it is less active than fraction III. 
Illustrated in Fig. 10 are the results of mucopeptide quantitative precipitin 
inhibition tests using purified mucopeptide fractions I  and III. As depicted in 
this figure, as little as 2 mg/ml of fraction III inhibited 90 % of the reaction be- 
tween Group B mucopeptide and a mucopeptide antiserum. Fraction I, which 
was essentially devoid of peptide residues,  gave minimal inhibition. These re- 
sults dearly suggest that the peptide residue is a major antigenic determinant 
of mucopeptide. 
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l~o. tO.  Inhibition of quantitative mucopepfide precipitin reaction with purified fraction 
III, the peptide rich moiety, and fraction I, hexosamine rich moiety. 
DISCUSSION 
Streptococcal mucopeptide extracted from cell walls by the hot formamide 
method is composed of N-acetylglucosamine, N-acetylmuramic acid, alanine, 
glutamic acid, lysine, and small variable amounts of glycine. The ratio of gluco- 
samine to muramic acid approaches one in mucopeptides derived from the var- 
ious streptococcal groups. Although the amino acid composition may vary to 
some extent from strain to strain, alanine,  lysine, and glutamic acid approach a 
mole ratio of approximately 4:1:1, a finding which is consistent with previous 
reports (26-29). 
A general pattern has emerged for the macromolecular structure of mucopep- 
tide, which is probably shared by most bacteria. Ghuysen and Salton (32) iso- 
lated a disaccharide composed of N-acetylglucosamine, N-acetylmuramic acid, 
and a peptide from Micrococcua lysodeikticus cell wails which had been digested 
with lysozyme. These and other studies have suggested that mucopeptide con- 
tains a hexosamine polymer which consists of repeating units of the disaccha- 168  STREPTOCOCCAL MUCOPEPTIDE 
ride. The peptide is linked to the backbone polymer through the muramic acid 
and, in turn, is cross-linked by an amino acid or peptide bridge. 
Evidence from several sources indicates that the structure of the mucopeptide 
of hemolytic streptococci  conforms to this general pattern. For example, Hey- 
mann et al. (25) isolated a disaecharide of the two amino sugars with an alanine 
substituent from Group A mucopeptide prepared by hot formamide extraction. 
The studies described here focus attention on the relationship  between the 
chemical structure and the antigenic  specificity of the mucopeptide  subunits. 
Digestion of cell walls of formamide-extracted mucopeptide yields, upon treat- 
ment with the S. a/bus enzymes, a peptide which has potent haptenic inhibitory 
properties when added to the mucopeptide precipitin reaction. This peptide con- 
sists of alanine, lysine, and glutamic acid in a mole ratio of 4:1:1. Release of 
this peptide from the mucopeptide is undoubtedly dependent upon the action 
of an N-acetylmuramyl L-alanine amidase,  which was identified by Ghuysen 
(31) as one of the S. a/bus cell wall lyric enzymes. 
While these findings identify the peptide as one antigenic determinant of the 
mucopeptide,  preliminary studies indicate that the hexosamine polymer in cer- 
tain instances  is also antigenic. The precipitin  reaction achieved with selected 
mucopeptide antisera is significantly inhibited by a mucopeptide fraction which 
contains a small percentage of peptides but is rich in hexosamines. Thus, immu- 
nization of animals with vaccines of bacteria or mucopeptide results in the pro- 
duction of antibodies directed against either the peptide moiety which is linked 
to the muramic acid, or against the hexosamine polymer. 
The biological significance of the immune response  to mucopeptide is not 
dear. There is, as yet, no evidence that mucopeptide antibodies have a protect- 
ive effect against challenge with homologous or heterologous bacteria. Mucopep- 
tide injected into the skin of rabbits induces severe necrotic  lesions, but the 
pathogenesis may be dependent upon a toxic process rather than a hypersensi- 
tivity phenomenon (33). Rotta et al. (34) injected rabbits intravenously with 
solubilized mucopeptide and achieved a febrile response similar to that observed 
with endotoxin. It is conceivable that the tolerance induced in rabbits injected 
with repeated doses of mucopeptides (34, 35) may be dependent upon mucopep- 
tide antibodies. 
SUMMARY 
Streptococcal  mucopeptide,  solubilized by either ultrasonic treatment or ly- 
sozyme, gave a precipitin  reaction with rabbit anfimucopepfide serum. A hap- 
tenic inhibitor of this reaction,  which was composed of alanine, glutamic acid, 
and lysine in a mole ratio of 4:1:1, was isolated from a Streptomyces a/bus en- 
zymes digest of Group D  cell walls by ion exchange chromatography. When 
selected anfisera were employed, greater than 90 % inhibition of the mucopep- 
tide quantitative precipitin reaction was achieved with 2 mg/ml of this inhibi- WALTER  W.  KARAJL~WA  AND  RICHARD  M.  KRAIYSE  169 
tor, whereas a hexosamlne fraction with minima] concentrations of amino acid 
residues was inactive in this respect. These results suggest that the peptide moi- 
ety is an antigenic determinant of mucopeptide. 
Preliminary results indicate that the hexosamiue polymer of the mucopeptide 
is a  secondary antigenic determinant. 
The authors are particularly grateful to  Dr Frank Young for his advice on the DEAE 
chromatography procedures. 
The authors owe a special debt of gratitude to Mr. Henry Lackland for his excellent tech- 
nical assistance. 
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